Shares Issued 159,227,298
Last Close 3/13/2017 $11.13
Tuesday March 14 2017 – News Release
Mr. Mark Zekulin reports
TWEED’S HOMEGROW COLLECTION NOW AVAILABLE
Canopy Growth Corp.’s Tweed Inc. has launched sales of a variety of top-tier seeds, under its HomeGrow Collection banner. Consisting of 10 cannabis varieties ranging from low and high tetrahydrocannabinol to cannabidiol options, the HomeGrow Collection is designed to meet the needs of a variety of patients managing a variety of symptoms.
“Our goal is to offer a wide selection of cannabis products in a variety of formats, from dried bud and blends, to oils,” said Mark Zekulin, president of Canopy Growth, Tweed’s parent company. “We know there is demand for high-quality cannabis seeds and we have long supported the patient’s individual right to grow their own medicine so this is a special day for our company.”
In addition to seeds, Tweed will offer authorized patients a stable interim supply of medical cannabis starting with a one-time $25 discount toward any available product in the Tweed shop.
Home growing was not a part of the regulatory framework for the first few years of Tweed’s operations, but became possible after activists and legal advocates fought to have it reintroduced into the federal regulations.
While the company is supportive of any patient choosing to grow at home, its primary focus remains on supplying ready-to-consume cannabis products to the rapidly growing number of Canadians choosing the convenience and quality that comes from Tweed’s focus on producing the best possible cannabis under the strictest controls and care.
Here’s to future growth.
Canopy Growth is a world-leading diversified cannabis company, offering diverse brands and curated cannabis strain varieties in dried and oil extract forms. Through its wholly owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over 500,000 square feet of indoor and greenhouse production capacity.
We seek Safe Harbor.
© 2017 Canjex Publishing Ltd.
This email was sent to you at email@example.com by Stockwatch (www.stockwatch.com) as part of your package of Stockwatch services, and in accordance with your email preferences on file. You may unsubscribe at any time, or change your email preferences within Your Account settings at the Stockwatch website. THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY. You may contact Stockwatch by email at firstname.lastname@example.org, by phone at 1-800-268-6397 (1-604-687-1500), or by mail to Stockwatch, PO Box 10371, 700 West Georgia Street, Vancouver, BC, V7Y 1J6, Canada. “Stockwatch” is a registered trademark of Canjex Publishing Ltd. Copyright © 2017, Canjex Publishing Ltd. All rights reserved.